Cardiac Pharmacotherapy


Cardiac pharmacotherapy plays a major role in the management of cardiovascular disease. Drug treatment leads to lifelong interventions in various cardiovascular conditions and increases life expectancy levels, leading to its role in increasing other debilitating symptoms. Various heart agents are available to treat a variety of heart conditions. There are about 6 organizations and 50 communities and universities that work on heart drugs. Of these, the main association of cardiology medical staff is the U.S. Cardiovascular drugs are available on the market that include cardiac glycosides, anticoagulants, antiarrhythmic agents, antigenic agents and antihypertensive agents.



 


  • Renin-Angiotensin-Aldosterone system
  • Neural Control of the cardiovascular system
  • Pharmacokinetics
  • Platelet/Clotting system

Related Conference of Cardiac Pharmacotherapy

October 20-21, 2025

39th World Congress on Heart Diseases

Frankfurt, Germany
November 13-14, 2025

6th Global Summit on Heart Congress

Paris, France
November 19-20, 2025

7th World Heart Congress

Tokyo, Japan
November 24-25, 2025

36th Annual Cardiologists Conference

Barcelona, Spain
November 27-28, 2025

32nd World Heartcare Summit

Paris, France
January 12-13, 2026

12th International Heart Conference

Dubai, UAE
March 18-19, 2026

15th World Heart Congress

Paris, France
March 23-24, 2026

41st World Cardiology Conference

London, UK
April 08-29, 2026

9th Annual Heart Rhythm Conference

Vienna, Austria
April 13-14, 2026

9th World Heart and Brain Conference

Tokyo, Japan
May 14-15, 2026

5th International Conference on Cardiology

Rome, Italy
May 21-22, 2026

15th World Congress on Cardiology

London, UK
July 29-30, 2026

30th World Cardiology Conference

Paris, France

Cardiac Pharmacotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in